These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23319035)

  • 1. Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.
    Al Ashgar HI; Khan MQ; Al-Ahdal M; Al Thawadi S; Helmy AS; Al Qahtani A; Sanai FM
    Saudi J Gastroenterol; 2013; 19(1):28-33. PubMed ID: 23319035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C. Genotypes and response to anti-viral therapy among Saudi patients.
    Al-Traif I; Handoo FA; Al-Jumah A; Al-Nasser M
    Saudi Med J; 2004 Dec; 25(12):1935-8. PubMed ID: 15711670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia.
    Shier MK; Iles JC; El-Wetidy MS; Ali HH; Al Qattan MM
    PLoS One; 2017; 12(9):e0184163. PubMed ID: 28863156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracing the epidemic history of hepatitis C virus genotypes in Saudi Arabia.
    Khan A; Al Balwi M; AlAyyar L; AlAbdulkareem I; Albekairy A; Aljumah A
    Infect Genet Evol; 2017 Aug; 52():82-88. PubMed ID: 28458032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.
    Alsaran K; Sabry A; Shaheen N
    Int Urol Nephrol; 2011 Sep; 43(3):865-73. PubMed ID: 20490669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients.
    Di Stefano M; Ismail MH; Leitner T; Faleo G; Elmnan Adem SA; Elamin MOME; Eltreifi O; Alwazzeh MJ; Fiore JR; Santantonio TA
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark.
    Eriksen MB; Jørgensen LB; Krarup H; Laursen AL; Christensen PB; Møller A; Schlichting P; Kuiken C; Bukh J; Weis N;
    J Med Virol; 2010 Nov; 82(11):1869-77. PubMed ID: 20872713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.
    Al Ashgar H; Helmy A; Khan MQ; Al Kahtani K; Al Quaiz M; Rezeig M; Kagevi I; Alshehri A; Al Kalbani A; Al Swat K; Dahab S; Elkum N; Al Fadda M
    Ann Saudi Med; 2009; 29(1):4-14. PubMed ID: 19139619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.
    AlQaraawi AM; Sanai FM; Al-Husseini H; Albenmousa A; AlSheikh A; Ahmed LR; Hersi A; Al-Otaibi MM; Syed M; Ali SM; Al-hamoudi W; Alswat KA; Abdo AA
    Dig Dis Sci; 2011 Apr; 56(4):1222-8. PubMed ID: 20931285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia.
    Shobokshi OA; Serebour FE; Skakni LI
    Saudi Med J; 2003 Jul; 24 Suppl 2():S87-91. PubMed ID: 12897908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C in dialysis units: the Saudi experience.
    Karkar A
    Hemodial Int; 2007 Jul; 11(3):354-67. PubMed ID: 17576302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.
    Alhamlan FS; Al-Ahdal MN; Khalaf NZ; Abdo AA; Sanai FM; Al-Ashgar HI; Elhefnawi M; Zaid A; Al-Qahtani AA
    J Med Virol; 2014 Feb; 86(2):224-34. PubMed ID: 24166351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.
    Roulot D; Bourcier V; Grando V; Deny P; Baazia Y; Fontaine H; Bailly F; Castera L; De Ledinghen V; Marcellin P; Poupon R; Bourlière M; Zarski JP; Roudot-Thoraval F;
    J Viral Hepat; 2007 Jul; 14(7):460-7. PubMed ID: 17576387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.
    Kumthip K; Chusri P; Pantip C; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
    J Med Virol; 2014 Aug; 86(8):1360-5. PubMed ID: 24777626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profile.
    Bawazir A; AlGusheri F; Jradi H; AlBalwi M; Abdel-Gader AG
    Virol J; 2017 Nov; 14(1):208. PubMed ID: 29096662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.
    Pellicelli AM; Romano M; Stroffolini T; Mazzoni E; Mecenate F; Monarca R; Picardi A; Bonaventura ME; Mastropietro C; Vignally P; Andreoli A; Marignani M; D'Ambrosio C; Miglioresi L; Nosotti L; Mitidieri O; Gentilucci UV; Puoti C; Barbaro G; Barlattani A; Furlan C; Barbarini G;
    BMC Gastroenterol; 2012 Nov; 12():162. PubMed ID: 23157720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
    Nicot F; Alric L; Barange K; Métivier S; Dramard JM; Combis JM; Castan B; Meurisse JJ; Payen JL; Garipuy D; Desmorat H; Peron JM; Thebault S; Morin T; Renou C; Barel P; Guerin B; Imbert Y; Sire S; Sauné K; Chatelut E; Izopet J
    J Med Virol; 2011 Mar; 83(3):437-44. PubMed ID: 21264864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4.
    Al-Ashgar HI; Khan MQ; Helmy A; Al-Thawadi S; Al-Ahdal MN; Khalaf N; Al-Qahtani A; Sanai FM
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):404-10. PubMed ID: 23470264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
    Legrand-Abravanel F; Colson P; Leguillou-Guillemette H; Alric L; Ravaux I; Lunel-Fabiani F; Bouviers-Alias M; Trimoulet P; Chaix ML; Hézode C; Foucher J; Fontaine H; Roque-Afonso AM; Gassin M; Schvoerer E; Gaudy C; Roche B; Doffoël M; D'Alteroche L; Vallet S; Baazia Y; Pozzetto B; Thibault V; Nousbaum JB; Roulot D; Coppere H; Poynard T; Payan C; Izopet J
    J Med Virol; 2009 Dec; 81(12):2029-35. PubMed ID: 19856464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.